CollPlant Biotechnologies Ltd. (CLGN)
0.401
0.00 (0.00%)
USD |
NASDAQ |
Jun 02, 16:00
0.401
0.00 (0.00%)
After-Hours: 20:00
CollPlant Biotechnologies Total Assets (Quarterly) : 9.183M for March 31, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Anika Therapeutics, Inc. | 179.39M |
| Perspective Therapeutics, Inc. | 410.77M |
| MiMedx Group, Inc. | 308.68M |
| Regentis Biomaterials Ltd. | -- |
| Xylo Technologies Ltd. | -- |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 4.297M |
| Shareholders Equity (Quarterly) | 4.886M |
| Debt to Equity Ratio | 0.5422 |
| Current Ratio | 2.268 |
| Net Debt Paydown Yield | 1.12% |